Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iNPLANT is a private medical device company focused on implant-delivery products used in aesthetic and reconstructive plastic surgery. Its lead products are sterile implant-delivery funnels designed to support a true no-touch insertion technique, reduce friction during placement, and improve procedural control for surgeons. The company markets the iNPLANT product family, including iNPLANT+, iNPLANT XL, and the original iNPLANT Funnel, for delivery of silicone gel and other silicone-based implants. iNPLANT emphasizes infection control, workflow efficiency, and reduced tissue contact in breast implant procedures. The business appears to operate commercially in the United States from Allendale, New Jersey, and is associated with parent company Proximate Concepts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iNPLANT.